Kymera Therapeutics, Inc.
KYMR
52 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 134,720 | $100.51 | $13.5M | 597,047(I) | View → |
| Jun 23, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 1,408 | $99.98 | $140.8K | 613,589(I) | View → |
| Jun 25, 2026 | Jun 25 10:00 PM | Noah GoodmanChief Business Officer | Sale | 5,000 | $114.00 | $570.0K | 50,195.438(D) | View → |
| Jun 25, 2026 | Jun 25 9:26 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 67,329 | $99.87 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 25 9:25 PM | Atlas Venture Fund X, LP | Proposed Sale | 480,992 | $99.87 | $48.0M | — | View → |
| Jun 25, 2026 | Jun 25 8:27 PM | NOAH GOODMAN | Proposed Sale | 5,000 | $99.87 | $499.4K | — | View → |
| Jun 24, 2026 | Jun 24 9:30 PM | Atlas Venture Fund X, LP | Proposed Sale | 118,178 | $98.25 | $11.6M | — | View → |
| Jun 24, 2026 | Jun 24 9:29 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 16,542 | $98.25 | $1.6M | — | View → |
| Jun 23, 2026 | Jun 23 10:14 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 173 | $99.45 | $17.2K | — | View → |
| Jun 23, 2026 | Jun 23 10:14 PM | Atlas Venture Fund X, LP | Proposed Sale | 1,235 | $99.45 | $122.8K | — | View → |
| Jun 22, 2026 | Jun 23 1:02 AM | Bruce BoothDirector | Sale | 31,798 | $103.75 | $3.3M | 613,762(I) | View → |
| Jun 22, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 246,330 | $98.52 | $24.3M | 617,663(I) | View → |
| Jun 18, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 115,056 | $91.01 | $10.5M | 647,914(I) | View → |
| Jun 17, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 116,812 | $90.34 | $10.6M | 662,042(I) | View → |
| Jun 22, 2026 | Jun 22 9:47 PM | Noah GoodmanChief Business Officer | Sale | 2,500 | $99.00 | $247.5K | 50,195.438(D) | View → |
| Jun 22, 2026 | Jun 22 9:28 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 34,152 | $90.43 | $3.1M | — | View → |
| Jun 22, 2026 | Jun 22 9:28 PM | Atlas Venture Fund X, LP | Proposed Sale | 243,976 | $90.43 | $22.1M | — | View → |
| Jun 22, 2026 | Jun 22 8:46 PM | NOAH GOODMAN | Proposed Sale | 2,500 | $90.43 | $226.1K | — | View → |
| Jun 18, 2026 | Jun 18 9:35 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 14,128 | $89.90 | $1.3M | — | View → |
| Jun 18, 2026 | Jun 18 9:35 PM | Atlas Venture Fund X, LP | Proposed Sale | 100,928 | $89.90 | $9.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Apr 29 9:00 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 215,559(D) | View → |
| Apr 22, 2026 | Apr 24 8:33 PM | Bruce BoothDirector | Option Exercise | 5,900 | $20.00 | 39,868(D) | View → |
| Apr 22, 2026 | Apr 24 8:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 300 | $43.50 | 58,263(D) | View → |
| Apr 15, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 1,300 | $43.50 | 58,463(D) | View → |
| Apr 14, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 5,251 | $43.50 | 59,763(D) | View → |
| Apr 15, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 2,200 | $14.18 | 5,641(D) | View → |
| Apr 14, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 4,159 | $14.18 | 7,841(D) | View → |
| Apr 9, 2026 | Apr 10 8:45 PM | Noah GoodmanChief Business Officer | Option Exercise | 2,500 | $21.05 | 97,500(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 14,640 | $29.64 | 68,633(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 4,600 | $14.18 | 0(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 7,400 | $14.18 | 4,600(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 7,600 | $29.64 | 83,273(D) | View → |
| Mar 25, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 24,727 | $29.64 | 90,873(D) | View → |
| Mar 23, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 84,400 | $29.64 | 115,600(D) | View → |
| Mar 20, 2026 | Mar 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 0(D) | View → |
| Mar 11, 2026 | Mar 11 10:51 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 20,000 | $43.50 | 60,548(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Brian AdamsChief Legal Officer | Grant/Award | 8,250 | $90.10 | 8,250(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jeremy G ChadwickChief Operating Officer | Grant/Award | 25,150 | $90.10 | 25,150(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Noah GoodmanChief Business Officer | Grant/Award | 18,450 | $90.10 | 18,450(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |